| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.51 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |